Artículos del autor

solaci

Other

AHA 2018 | Canakinumab Reduces Hospitalization for Cardiac Failure in Respondents

The benefit was dose-dependent reduction, regardless the presence of absence of baseline cardiac failure. Patients with prior...
solaci -
Acute coronary syndromes

AHA 2018 | Use of Balloon Counterpulsation According to IABP-SHOCK II Trial

Following up on the 30 day and one year effect, the IABP-SHOCK II trial long term outcomes...
solaci -
Other

AHA 2018 | Endocarditis Prophylaxis More Limited after AHA 2007 Guidelines

The incidence of infective endocarditis had decreased after AHA 2007 recommendations. At present, some patients are not...
solaci -
Chronic Ischemic cardiopathy

AHA 2018 | Freedom Long-Term Follow-up: Still in Favor of CABG

Nearly 8 years later, CABG maintains its benefit over PCI-DES in terms of mortality in diabetic patients...
solaci -
CONGRESS

UDATES IN INTERVENTIONAL CARDIOLOGY

Find valuable scientific articles from prior SOLACI Congress and outstanding world class events on Interventional Cardiology.
solaci -
AHA 2018

AHA 2018

Here you will find the highlights of the AHA 2018, held on November 10-12 in the city...
solaci -
Coronary disease

Clinical Improvement Without Ventricular Function Improvement After CTO

The benefits offered to patients by attempting the rechanneling of a chronic total occlusion are still unclear....
solaci -
Structural heart disease

CoreValve US Pivotal High Risk Trial: at 5 years, similar results

Courtesy of Dr. Carlos Fava. We are well aware of transcatheter aortic valve replacement’s (TAVR) effect in high-risk...
solaci -